Dose-escalating RCT in 122 infants born <29 weeks with severe BPD: sildenafil vs placebo (3:1) did not increase hypotension (1/92 vs 0/30); serious adverse events occurred in 8% vs 13%. Respiratory severity scores did not differ; efficacy needs a larger trial.
RCTn = 122
Jackson et al. Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia (SILDI-SAFE): A Randomized Controlled Trial